Hippocampal hypometabolism predicts cognitive decline from normal aging

Neurobiology of Aging

Volumn 29, Issue 5, 2008, Pages 676-692

  Mosconi, Lisa ^a   De Santi, Susan ^a   Li, Juan ^a   Tsui, Wai Hon ^a,b   Li, Yi ^a   Boppana, Madhu ^a   Laska, Eugene ^b   Rusinek, Henry ^a   de Leon, Mony J ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Alzheimer's disease; Early detection; Glucose metabolism; Hippocampus; Mild cognitive impairment; Normal aging

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; AGING; COGNITION DISORDERS; DEMENTIA; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLUCOSE METABOLISM DISORDERS; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; STATISTICS AS TOPIC;

EID: 38149006292     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.12.008     Document Type: Article

References (57)

1. Albin R.L., Minoshima S., DAmato C.J., Frey K.A., Kuhl D.E., and Sima A.A.F. Fluoro-deoxyglucose positron emission tomography in diffuse lewy body disease. Neurology 47 (1996) 462-466
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition), 4th ed., American Psychiatric Association, Washington, D.C., 1994.
3. Anchisi D., Borroni B., Franceschi M., Kerrouche N., Kalbe E., Beuthien-Beumann B., Cappa S., Lenz O., Ludecke S., Marcone A., Mielke R., Ortelli P., Padovani A., Pelati O., Pupi A., Scarpini E., Weisenbach S., Herholz K., Salmon E., Holthoff V., Sorbi S., Fazio F., and Perani D. Heterogeneity of brain glucose metaboism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch. Neurol. 62 (2005) 1728-1733
4. Ball M.J., Hachinski V., Fox A., Kirshen A.J., Fisman M., Blume W., Kral V.A., and Fox H. A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 1 (1985) 14-16
5. Berent S., Giordani B., Foster N., Minoshima S., Lajiness-O'Neill R., Koeppe R., and Kuhl D.E. Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. J. Psychiat. Res. 33 (1999) 7-16
6. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82 (1991) 239-259
7. Chetelat G., Desgranges B., De La Sayette V., Viader F., Eustache F., and Baron J.C. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease?. Neurology 60 (2003) 1374-1377
8. de Leon M.J., Convit A., Wolf O.T., Tarshish C.Y., De Santi S., Rusinek H., Tsui W., Kandil E., Scherer A.J., Roche A., Imossi A., Thorn E., Bobinski M., Caraos C., Lesbre P., Schlyer D., Poirier J., Reisberg B., and Fowler J. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET). Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10966-10971
9. De Santi S., de Leon M.J., Rusinek H., Convit A., Tarshish C.Y., Boppana M., Tsui W.H., Daisley K., Wang G.J., and Schlyer D. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol. Aging 22 (2001) 529-539
10. De Santi S., Li J., Reisberg B., Notkin-Schwab R., Rogers K., Williams S., Tierney M., Ferris S., and de Leon M.J. How good are single amnestic and multiple domains for characterizing MCI patients at risk for AD?. Alzh. Dementia 1 (2005) S81
11. den Heijer T., Geerlings M.I., Hoebeek F.E., Hofman A., Koudstaal P.J., and Breteler M. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch. Gen. Psychiat. 63 (2006) 57-62
12. Diggle P.J., Heagerty P., Liang K.-Y., and Zeger S.C. Analysis of Longitudinal Data (2002), Oxford University Press, New York
13. Drzezga A., Grimmer T., Riemenschneider M., Lautenschlager N., Siebner H., Alexopoulus P., Minoshima S., Schwaiger M., and Kurz A. Prediction of individual outcome in MCI by means of genetic assessment and 18F-FDG PET. J. Nucl. Med. 46 (2005) 1625-1632
14. Drzezga A., Lautenschlager N., Siebner H., Riemenschneider M., Willoch F., Minoshima S., Schwaiger M., and Kurz A. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur. J. Nucl. Med. 30 (2003) 1104-1113
15. Folstein M. The mini-mental state examination. In: Crook T., Ferris S.H., and Bartus R. (Eds). Assessment in Geriatric Psychopharmacology (1983), Mark Powley Associates, New Canaan 47-51
16. Fox N.C., Crum W.R., Scahill R.I., Stevens J.M., Janssen J.C., and Rossor M.N. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358 (2001) 201-205
17. Fox N.C., Warrington E.K., and Rossor M.N. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet 353 (1999) 2125
18. Frank R.A., Galasko D., Hampel H., Hardy J., de Leon M.J., Mehta P.D., Rogers J., Siemers E., and Trojanowski J.Q. Biological markers for therapeutic trials in Alzheimer's disease: proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol. Aging 24 (2003) 521-536
19. Friston K.J., Holmes A.P., Worsley K.J., Poline J.-P., Frith C.D., and Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapping 2 (1995) 189-210
20. Friston K.J., Stephan K.E., Lund T.E., Morcom A., and Kiebel S.J. Mixed-effects and fMRI studies. Neuroimage 24 (2004) 244-252
21. Gauthier S., Reisberg B., Zaudig M., Petersen R.C., Ritchie K., Broich K., Belleville S., Brodaty H., Bennett D., Cummings J., de Leon M.J., Feldman H., Ganguli M., Hampel H., Scheltens P., Tierney M., Whitehouse P., and Winblad B. Mild cognitive impairment. Lancet 367 (2006) 1262-1270
22. Geerlings M.I., Jonker C., Bouter L.M., Ader H.J., and Schmand B. Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. Am. J. Psychiat. 156 (1999) 531-537
23. Hachinski V.C., Lassen N.A., and Marshall J. Multi-infarct dementia, a cause of mental deterioration in the elderly. Lancet 2 (1974) 207-210
24. Haxby J.V., Grady C.L., Koss E., Horwitz B., Heston L., Schapiro M., Friedland R.P., and Rapoport S.I. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch. Neurol. 47 (1990) 753-760
25. Hosmer Jr. D.W., and Lemeshow S. In: Hosmer Jr. D.W., and Lemeshow S. (Eds). Parametric Regression Models (1999), Wiley, New York, NY 289-299
26. Ibanez V., Pietrini P., Alexander G.E., Furey M.L., Teichberg D., Rajapakse J.C., Rapoport S.I., Schapiro M., and Horwitz B. Regional gluose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50 (1999) 1585-1593
27. Jack C.R., Shiung M.M., Gunter J.L., O'Brien P.C., Weigand S.D., Knopman D.S., Boeve B.F., Ivnik R.J., Smith G.E., Cha R.H., Tangalos E.G., and Petersen R.C. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62 (2004) 591-600
28. Jonker C., Geerlings M.I., and Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int. J. Geriatr. Psych. 15 (2000) 983-991
29. Klunk W.E., Engler H., Nordberg A., Yanming W., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni, Mathis C.A., and Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55 (2004) 306-319
30. Maldjian J.A., Laurienti P.J., Kraft R.A., and Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19 (2003) 1233-1239
31. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health & Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
32. Meltzer C.C., Leal J.P., Mayberg H.S., Wagner Jr. H.N., and Frost J.J. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J. Comp. Assist. Tomogr. 14 (1990) 561-570
33. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 24 (1999) 521-529
34. Minoshima S., Frey K.A., Foster N.L., and Kuhl D.E. Preserved pontine glucose metabolism in Alzheimer's Disease: a reference region for functional brain image (PET) analysis. J. Comp. Assist. Tomogr. 19 (1995) 541-547
35. Minoshima S., Giordani B., Berent S., Frey K.A., Foster N.L., and Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42 (1997) 85-94
36. Morrison J.H., and Hof P.R. Life and death of neurons in the aging brain. Science 278 (1997) 412-419
37. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. Eur. J. Nucl. Med. 32 (2005) 486-510
38. Mosconi L., De Santi S., Li Y., Li J., Zhan J., Tsui W.H., Boppana M., Pupi A., and de Leon M.J. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET. Eur. J. Nucl. Med. 33 (2006) 210-221
39. Mosconi L., Perani D., Sorbi S., Herholz K., Nacmias B., Holthoff V., Salmon E., Baron J.-C., De Cristofaro M.T.R., Padovani A., Borroni B., Franceschi M., Bracco L., and Pupi A. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology 63 (2004) 2332-2340
40. Mosconi L., Tsui W.H., De Santi S., Rusinek H., Li J., Convit A., Li Y., and de Leon M.J. Reduced hippocampal metabolism in mild cognitive impairment and Alzheimer's disease: automated FDG-PET Image Analysis. Neurology 64 (2005) 1860-1867
41. Nestor P.J., Fryer T.D., Smielewski P., and Hodges J.R. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann. Neurol. 54 (2003) 343-351
42. Nestor P.J., Scheltens P., and Hodges J.R. Advances in the early detection of Alzheimer's disease. Nat. Med. 10 (2004) S34-S41
43. Nicoll J.A.R., Wilkinson D., Holmes C., Steart P., Markham H., and Weller R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-[beta] peptide: a case report. Nat. Med. 9 (2003) 448-452
44. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56 (1999) 303-308
45. Purser J.L., Fillenbaum G.G., and Wallace R.B. Memory complaint is not necessary for diagnosis of mild cognitive impairment and does not predict 10-year trajectories of functional disability, word recall, or short portable mental status questionnaire limitations. J. Am. Geriatr. Soc. 54 (2006) 335-338
46. Reed B.R., Jagust W.J., Seab J.P., and Ober B.A. Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease. Neurology 39 (1989) 1537-1539
47. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., and Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 284-289
48. Reisberg B., Ferris S.H., de Leon M.J., and Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psychiat. 139 (1982) 1136-1139
49. Reivich M., Alavi A., Wolf A., Fowler J., Russell J., Arnett C., MacGregor R.R., Shiue C.Y., Atkins H., Anand A., Dann R., and Greenberg J. Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J. Cereb. Blood Flow Metab. 5 (1985) 179-192
50. Rusinek H., and Chandra R. Accuracy of tissue volume determination from MRI: a phantom study. Invest Radiol. 28 (1993) 890-895
51. Rusinek H., De Santi S., Frid D., Tsui W., Tarshish C., Convit A., and de Leon M.J. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 229 (2003) 691-696
52. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
53. Silverman D.H.S., Small G.W., Chang C.Y., Lu C.S., Kung de Aburto M.A., Chen W., Czernin J., Rapoport S.I., Pietrini P., Alexander G.E., Schapiro M.B., Jagust W.J., Hoffman J.H., Welsh-Bohmer K.A., Alavi A., Clark C.M., Salmon E., de Leon M.J., Mielke R., Cummings J.L., Kowell A.P., Gambhir S.S., Hoh C.K., and Phelps M.E. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 286 (2001) 2120-2127
54. Small G.W., Mazziotta J.C., Collins M.T., Baxter L.R., Phelps M.E., Mandelkern M.A., Kaplan A., LaRue A., Adamson C.F., Chang L., Guze B.H., Corder E.H., Saunders A.M., Haines J.L., Pericak-Vance M.A., and Roses A.D. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. JAMA 273 (1995) 942-947
55. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M.H., Patlak C.S., Pettigrew K.D., Sakurada O., and Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28 (1977) 897-916
56. Talairach J., and Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain (1988), Thieme, Stuttgart
57. Vander Borght T., Minoshima S., Giordani B., Foster N.L., Frey K.A., Berent S., Albin R.L., Koeppe R.A., and Kuhl D.E. Cerebral metabolic differences in Parkinson's and Alzheimer's disease matched for dementia severity. J. Nucl. Med. 38 (1997) 797-802